Detalhe da pesquisa
1.
Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a.
J Transl Med
; 21(1): 232, 2023 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37004031
2.
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer.
Int J Mol Sci
; 24(21)2023 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37958677
3.
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests.
Int J Mol Sci
; 23(21)2022 Nov 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36362392
4.
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(10): 1458-1467, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34543613
5.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34875670
6.
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Breast Cancer Res Treat
; 182(2): 401-409, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32500397
7.
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients.
Future Oncol
; 16(22): 1629-1637, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32501121
8.
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Lancet Oncol
; 20(10): 1360-1369, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31494037
9.
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
Breast Cancer Res
; 21(1): 71, 2019 05 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31142370
10.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
Lancet Oncol
; 19(4): 474-485, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29482983
11.
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project.
BMC Cancer
; 18(1): 932, 2018 Sep 27.
Artigo
Inglês
| MEDLINE | ID: mdl-30261866
12.
It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature.
BMC Cancer
; 18(1): 146, 2018 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29409458
13.
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?
Future Oncol
; 13(30): 2791-2797, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29182361
14.
Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
BMC Cancer
; 16: 375, 2016 07 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27377827
15.
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy.
Breast Cancer Res Treat
; 154(1): 127-32, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26424165
16.
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study.
Anticancer Drugs
; 26(1): 117-22, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25115342
17.
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues.
Breast J
; 25(6): 1310-1311, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31338934
18.
Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs).
Cancer Treat Rev
; 123: 102672, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38118302
19.
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients.
Breast
; 75: 103713, 2024 Mar 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38493590
20.
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention.
Biomolecules
; 13(4)2023 04 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37189400